Related Experiment Videos
Role of IL-4 in persistent IgE formation
1Dept of Immunology, Erasmus University, Rotterdam, The Netherlands.
The European Respiratory Journal. Supplement
|August 1, 1996
Summary
Targeting interleukin-4 (IL-4) alone may not reduce persistent immunoglobulin E (IgE) in allergies. Blocking IL-4 might even prolong its effects and increase IgE-producing B-cells.
Area of Science:
- Immunology
- Allergy Research
- Immunotherapy
Background:
- Antigen-specific immunoglobulin E (IgE) production requires B-cell and T-helper (Th2) cell interaction, providing CD40 ligation and interleukin-4 (IL-4).
- Current cytokine-mediated immunotherapy for allergic diseases focuses on inhibiting IL-4 production or action.
Purpose of the Study:
- To evaluate the sufficiency of solely inhibiting IL-4 for reducing persistent IgE levels in allergic conditions.
- To investigate potential counterintuitive effects of anti-IL-4 strategies.
Main Methods:
- Analysis of mouse model systems to observe the effects of IL-4 exposure on B-cell populations and IgE production.
- Assessment of the dependency of IgE formation on IL-4 and T-cell interaction in specific B-cell subsets.
Main Results:
- Inhibition of IL-4 via soluble receptors or binding proteins may paradoxically increase IL-4 persistence and effects.
- IL-4 exposure generates gamma 1,epsilon-double positive B-cells that sustain elevated serum IgE.
- These B-cells exhibit partial independence from IL-4 and T-cell cognate interaction for IgE synthesis.
Conclusions:
- Strategies solely targeting IL-4 inhibition may be insufficient for decreasing persistent IgE levels in allergic patients.
- The generation of partially IL-4- and T-cell-independent IgE-producing B-cells complicates anti-IL-4 immunotherapy approaches.